Salute e Benessere

New Kidney Health Alliance Elevates Chronic Kidney Disease on Global Health…

CKD is one of the most neglected public health crises of our time.Globally, CKD affects nearly 840 million people. About 90% of CKD patients are unaware of their status. This can have dire consequences: CKD is incurable, and when left unmanaged, it can lead to kidney failure, necessitating dialysis or kidney transplants. CKD is one of the most neglected public health crises of our time.Globally, CKD affects nearly 840 million people. About 90% of CKD patients are unaware of their status...
PR Newswire
19/09/2023

IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2023

Aggregatedpresentationbydayandbymarket NameofissuerIdentificationcodeof issuer(Legal Entity Identifier)Day of transactionIdentificationcodeof financialinstrumentAggregated daily volume(innumber of shares)Dailyweightedaveragepriceof the purchased shares *Market(MICCode) IPSEN549300M6SGDPB4Z94P1111/09/2023FR0010259150154121.41CEUXIPSEN549300M6SGDPB4Z94P1111/09/2023...
Nasdaq GlobeNewswire
19/09/2023

2023 half year results

Press release Ecully , September 19, 2023 – 6 p.m. H1 2023 resultsRevenue growth in H1 (+75%)Gross margin of €3.9m (72% of revenue)Continued investmentNew financing to support developmentIn thousands of eurosConsolidated accountsH1 2023H1 2022Revenue5,4323,113 Cost of sales(1,509)(1,036) Gross margin*% of revenue3,92372%2,07767% Net operating expenses Of which running costs (5,556)(2,355)...
Nasdaq GlobeNewswire
19/09/2023

Transactions in connection with share buy-back program

Company announcement no. 48 - 2319 September 2023 Transactions in connection with share buy-back program On 3 August 2023 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company announcement no. 38 - 23. The program will be executed in accordance with the principles of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbor rules...
Nasdaq GlobeNewswire
19/09/2023

Antimicrobial Resistance Surveillance Market worth $7.7 billion |…

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21323165 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21323165 Browse in-depth TOC on "Antimicrobial Resistance Surveillance Market" 158 - Tables 58 - Figures 234 - Pages Antimicrobial Resistance Surveillance Market Scope: The diagnostic kits segment is expected to account for the largest share of the market during the forecast...
PR Newswire
19/09/2023

Calliditas Therapeutics to Present Nefecon Data at the 17th International…

Poster presentation details are below and will be available on the Presentation and Publication page on the Calliditas' corporate website following the meeting. Poster presentation details are below and will be available on the Presentation and Publication page on the Calliditas' corporate website following the meeting. Oral Presentation Details: Title:Analysis of the NefIgArd Part A study population confirms Nefecon suppresses circulating levels of BAFF, APRIL, and soluble BCMA...
PR Newswire
19/09/2023

Fully Automatic Electrolyte Analyzers Market to reach $766.5 Million, globally…

Request Sample of the Report on Fully Automatic Electrolyte Analyzers Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/111551 Request Sample of the Report on Fully Automatic Electrolyte Analyzers Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/111551 The concentration of electrolytes in the blood, plasma, and other bodily fluids can be determined using a fully automatic electrolyte analyzer. Electrolytes are electrically charged ions...
PR Newswire
19/09/2023

The Global Digital Therapeutics Market is expected to grow at 19.6% CAGR till…

Owing to their multiple benefits, including ease of access, shorter development timelines, versatile delivery platforms, decreased cost of treatment, personalized treatment options, enhanced medication adherence, promotion of healthy lifestyle and remote access to healthcare providers for patients and vice versa, digital therapeutics have emerged as a promising alternative to conventional medication. The benefits offered by these solutions and the growing demand for remote and digital solutions…
PR Newswire
19/09/2023

Patchouli Oil Market to Reach $64.4 Million, Globally, by 2032 at 4.1% CAGR…

Request Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/3119 Request Sample Copy of the Report:https://www.alliedmarketresearch.com/request-sample/3119 Prime Determinants of Growth Various therapeutic benefits associated with the use of patchouli oil, growing demand for personal care & cosmetic products, and the rising adoption of patchouli oil in aromatherapy are the factors anticipated to drive the patchouli oil market growth during the...
PR Newswire
19/09/2023

Angel Group's First Industrialized Strain of Probiotics Anchors Strategic…

Angel's R&D team regularly visited Tibet and collected over 100 precious samples of plateau probiotics from more than 20 counties and townships across five cities and one district, and continually expands its Qinghai Tibet Plateau Probiotic Bank, which is the main driving force for tackling the bottleneck of plateau probiotics development. Angel's R&D team regularly visited Tibet and collected over 100 precious samples of plateau probiotics from more than 20 counties and townships…
PR Newswire
19/09/2023

Outcomes4Me Announces Investments to Accelerate Life-Saving Treatments for…

"This is an important and significant time in our company history," said Maya R. Said, Sc.D., Founder and CEO of Outcomes4Me. "Innovation is useless if it does not reach patients, and our data shows that more than a third of patients diagnosed with cancer in the United States do not have access to the latest treatments and this disparity is increasing as we move into the world of precision oncology. With more than 150,000 cancer-patient members already using our platform, I am…
PR Newswire
19/09/2023

Apparel Impact Institute Announces First Grant Recipients from its Climate…

The application was designed by the CSP Advisory Council, which is composed of industry leaders: Kurt Kipka, Aii Chief Impact Officer; Linda Greer, Scientist and Consultant; Phil Patterson, Managing Director at Colour Connections Textile Consultancy; Beth Jensen, Director, Climate+ Impact at Textile Exchange; Crispin Wong, Senior Director of Product Sustainability and Environment at Lululemon; Mallory McConnell, Vice President of Corporate Responsibility at PVH Corp.; and Abhishek Bansal…
PR Newswire
19/09/2023

AMO Pharma Announces Preclinical Data Showing AMO-02 Improves Muscle Function…

In January 2023, Brock University and AMO Pharma announced initiation of a research partnership supported by a grant from the Brock-Niagara Validating, Prototyping and Manufacturing Institute (VPMI) to investigate the potential utility of GSK3β inhibitors in the treatment of DMD, a rare genetic disorder characterized by progressive muscle degeneration and weakness. A team of researchers at Brock University led by professors Val Fajardo, PhD, and Rebecca MacPherson, PhD, investigated the effects…
PR Newswire
19/09/2023

Akari Therapeutics to Host Key Opinion Leader Webinar on Hematopoietic Stem Cell…

Event on October 19, 2023 will feature Sonata Jodele, MD and Professor Rob WynnBOSTON and LONDON, Sept.19, 2023(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the company will host a virtual key opinion leader event on October 19, 2023 at 11:30 am ET to discuss the patient care landscape for hematopoietic stem cell transplant-related thrombotic...
Nasdaq GlobeNewswire
19/09/2023

Mediq unveils new era in the UK: A journey of efficiency, innovation and…

Mediq takes pride in working collaboratively with customers to help them achieve their healthcare goals, making the anticipated growth of the business an exciting and welcome opportunity for many. The company's continuous investment into products, services and solutions in the UK, is a meaningful effort to fulfil their mission of delivering the most efficient outcomes for European Healthcare. Mediq takes pride in working collaboratively with customers to help them achieve their healthcare...
PR Newswire
19/09/2023

ALSA Ventures launches novel Gene Therapy portfolio company Axovia Therapeutics…

Developing the first gene therapy to treat diseases caused by cilia dysfunctionAXV101 targets retinal dystrophy for Bardet-Biedl Syndrome (BBS) patientsFDA Orphan Drug Designation and Rare Pediatric Disease Designation achievedFirst-in-man study planned to start in late 2024/early 2025Six potentially transformative therapies for ciliopathies are in its pipelineLONDON, Sept.19, 2023(GLOBE NEWSWIRE) --ALSA Ventures, a UK-based, therapeutics-focused venture capital fund,...
Nasdaq GlobeNewswire
19/09/2023

Oncolytics Biotech® Announces Fireside Chat at the Cantor Global Healthcare…

Company management will also be participating in one-on-one investor meetings at the conference. To schedule a meeting, please submit a request on the conference website, contact your Cantor Fitzgerald representative, or email jpatton@oncolytics.ca. Company management will also be participating in one-on-one investor meetings at the conference. To schedule a meeting, please submit a request on the conference website, contact your Cantor Fitzgerald representative, or emailjpatton@oncolytics...
PR Newswire
19/09/2023

NecstGen and ProteoNic report development of improved viral vectors through the…

Frank Pieper, CEO of ProteoNic, commented "We are excited to see our collaboration with Necstgen achieving this important milestone. We will continue our efforts aimed at improving AAV and LV vectors, catering to both transient production systems and stable viral producer cell lines". Frank Pieper, CEO of ProteoNic, commented "We are excited to see our collaboration with Necstgen achieving this important milestone. We will continue our efforts aimed at improving AAV and LV…
PR Newswire
19/09/2023

Invitation to Essity's webcast - Innovating for sustainable and profitable…

The webcast will start with a presentation of Essity and its strategic priorities for increased value creation and will subsequently focus on how Essity innovates to ensure profitable and sustainable growth. The event will be broadcast live from Stockholm, Sweden, with members of Essity's Executive Management Team, concluding with a Q&A session. The webcast will start with a presentation of Essity and its strategic priorities for increased value creation and will subsequently focus on how...
PR Newswire
19/09/2023

Implantica announces two independent scientific presentations on RefluxStop™…

"At Implantica, we are delighted to see that such respected surgeons and leaders in the reflux world are seeing great patient outcomes from the RefluxStop™ therapy. We appreciate that they are making invaluable efforts to share their experience with other medical experts. We are honored to see the momentum building about the RefluxStop™ procedure in the surgical community, and this independent research work is essential to ensure that the RefluxStop treatment reaches the patients. Once…
PR Newswire
19/09/2023

Press Release: Sanofi supporting vulnerable communities as part of commitment to…

Sanofi supportingvulnerable communities as part ofcommitment to social impact and fight against climate changeParis, September19 , 2023 –As global leaders gather at the United Nations' 78 thGeneral Assembly, Sanofi is delivering vital support to communities beset by climate turbulence and by unmet medical needs. These critical initiatives come as theglobal healthcare company confirms its commitment to positively impact society bytackling climate...
Nasdaq GlobeNewswire
19/09/2023

Intravacc announces publication of In Vitro alternative to replace animal…

Intravacc and Sanquin Diagnostic Services optimized thein vitroMonocyte Activation Test (MAT) for OMV vaccines MAT test potential replacement for the traditional rabbit pyrogen testing (RPT) for vaccinesThe implementation of the MAT reduces the use of animals for vaccine safety testingArticle published in the peer reviewed journal Scientific ReportsBILTHOVEN, Netherlands, Sept.19, 2023(GLOBE NEWSWIRE) --Intravacc, aLeading Contract Development and manufacturing...
Nasdaq GlobeNewswire
19/09/2023

Nasal Spray VIRALEZE™ For Respiratory and Cold Viruses, Including New Strains

VIRALEZE™, developed by Starpharma, is available for purchase online at www.viraleze.co / www.viraleze.co.uk and through certain retail partners. For further information, visit the official websites. VIRALEZE™, developed by Starpharma, is available for purchase online atwww.viraleze.co/ www.viraleze.co.uk and through certain retail partners. For further information, visit the official websites. Starpharma is also currently completing a post-market study of VIRALEZE™ at St Peter's...
PR Newswire
19/09/2023

PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new…

PHAXIAM Therapeutics extends its phage portfolio toKlebsiella pneumoniae, a new resistant and aggressive bacterial targetKlebsiella pneumoniaeis responsible for severeinfections and stands out for its high resistance to antibioticsPHAXIAM'santi- Klebsiella pneumoniaephages to enter pre-clinical development to assess their efficacy in lung , blood and urinary tract infections, in addition to the three major targets already developed ( S...
Nasdaq GlobeNewswire
19/09/2023
Altri  Comunicati